Diagnos Laboratorium Utama Tbk. vs Nanotech Indonesia Global Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Nanotech Indonesia Global Tbk. trades at Rp34 (market cap 149.99B, 60.41M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.1× Nanotech Indonesia Global Tbk.'s market cap, and Nanotech Indonesia Global Tbk. is more actively traded (60.41M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | NANO | |
|---|---|---|
Market Cap | 319B | 149.99B |
Volume | 7.6K | 60.41M |
Lot | 76 | 604.05K |
Turnover | 1.74M | 2.05B |
Average Price | 229.21 | 33.89 |
Value | 1.74M | 2.05B |
Indicative Equilibrium Price | 232 | — |
Indicative Equilibrium Volume | 200 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Nanotech Indonesia Global Tbk (the Company) was established on May 22, 2019 based on the Notarial Deed No. 374 of Nurlisa Uke Desy, S.H. M.Kn. The Company has operated since 2019.
Read more on NANO →